Light therapy for PERIPHERAL NEUROPATHY
Light therapy is the non-thermal delivery of waves of light energy with a therapeutic benefit. SYMBYX’s medical-grade DermaCare laser is easy to use at home and ARTG/CE listed for reduction in chronic pain and inflammation.
There are currently 5,000 + peer-reviewed scientific studies reporting on the incident-free, protective and restorative properties of light therapy for a number of health conditions.
SYMBYX’s medical-grade DermaCare laser is a flexible, compact and easy to use at home device.
A non-surgical and non-thermal treatment.
Positive changes include improved scar healing and inflammation, promoted tissue healing and pain relief in fingers and toes.
History of Light Therapy
In 1903, the Nobel Prize in medicine was awarded to Danish Physician, Niels Ryberg Finsen, for his work in treating Smallpox and Tuberculosis with light.
Further interest in the field was pioneered by Professor Endre Mester, a Hungarian physician and scientist, who in 1967 successfully used light to heal wounds and regrow hair in mice and people.
NASA also experimented frequently with light in the 1970's and 1980's and successfully used LED light to grow flowers in space. Today, light is used to pre-prime patients prior to surgery (including cardiovascular surgery) as well as for several neurodegenerative disorders.
What is Peripheral Neuropathy and How Common is it?
Peripheral Neuropathy (PN) typically refers to nerve mediated pain in the digits – including fingers, feet and toes.It is due to nerve and capillary (small blood vessel) damage, typical the after-effects of chemotherapy, diabetes and/or shingles.
The incidence of PN in diabetics is as high as 50% while it is estimated at 30-40% in post chemotherapy patients.The pain is felt as a sharp stabbing or burning sensation. Intermittent pins and needles and numbness are also reported. PN negatively effects balance, gait, fine and gross motor skills and general patient quality of life.
HOW DOES DERMA CARE HELP?
DermaCare is a red light laser, developed by SYMBYX, which emits light energy at 635 nanometers.
At this wavelength, the power of the DermaCare diode physical properties are sufficient to reduce inflammation and metabolise increased nitric oxide (a naturally occurring molecular coordinator of cell energy demands and blood vessel dilation) levels such that more oxygenated blood flows to the patient’s digits.
This increased blood supply heals damaged tissue over-time. DermaCare also acts as a natural analgesic (pain killer) as it blocks fast axonal nerve transmission, which are nerve cells that transmit pain sensations from the digits to the brain.